Differential expression of receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL) in rheumatoid arthritis synovial tissue and peripheral blood cells

被引：0
|
作者：
Krystufkova, O.
Sinkora, J.
Niederlova, J.
Rehakova, Z.
Jarosova, K.
Ruzickova, S.
Vencovsky, J.
机构：
[1] Inst Rheumatol, Dept Mol Biol & Immunogenet, Prague 2, Czech Republic
[2] DakoCytomation AG, Brno, Czech Republic
[3] Fac Mil Hlth Sci UD, Dept Radiobiol, Hradec Kralove, Czech Republic
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [1] Methylation of receptor activator of nuclear factor kappa ligand (RANKL) gene in rheumatoid arthritis patients
    Ramzy, Manal
    Gharbia, Ola M.
    Seleem, Amal K.
    Mohamed, Karima
    Marzouk, Rehab E.
    EGYPTIAN RHEUMATOLOGIST, 2023, 45 (02): : 171 - 176
  • [2] Macrophage migration inhibitory factor upregulates expression of receptor activator of NF-kappa B ligand(RANKL) in rheumatoid arthritis synovial fibroblasts
    Lee, Sang Heon
    Kim, Kyoung Woon
    Kim, Hae Rim
    Cho, Mi La
    Min, Jun Ki
    Seo, Youngil
    Jung, Young-Ok
    Lee, Chang-Keun
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [3] Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis
    Johansson, Linda
    Arlestig, Lisbeth
    Kokkonen, Heidi
    Rantapaa-Dahlqvist, Solbritt
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] The receptor activator of nuclear factor kappa-B ligand and the osteoprotegerin in synovial fluid at patients with psoriatic and rheumatoid arthritis
    Ciacli, C.
    ALLERGY, 2012, 67 : 288 - 288
  • [5] Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Marginal Jawbone Loss Predates the Onset of Rheumatoid Arthritis
    Kindstedt, Elin
    Johansson, Linda
    Palmqvist, Py
    Holm, Cecilia Koskinen
    Kokkonen, Heidi
    Johansson, Ingegerd
    Lundberg, Pernilla
    Rantapaa-Dahlqvist, Solbritt
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND (RANKL) AND SCLEROSTIN ARE RELATED TO JOINT DESTRUCTION IN EARLY RHEUMATOID ARTHRITIS
    Rantapaa-Dahlqvist, S.
    Boman, A.
    Kokkonen, H.
    Berglin, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 679 - 680
  • [7] Chemokine receptor expression on the peripheral blood and synovial tissue B cells in rheumatoid arthritis patients
    Takada, K
    Nanki, T
    Hayashida, K
    Taniguchi, K
    Miyasaka, N
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S86 - S87
  • [8] Study of the serum level of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in patients with rheumatoid arthritis
    Wagdy, E.
    Moghazy, T. F.
    Ragab, W. S.
    Aref, T. Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 372 - 372
  • [9] Receptor activator of nuclear factor kappa-B ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
    Burska, A. N.
    El-Jawhari, J. J.
    Wu, J.
    Wakefield, R. J.
    Marzo-Ortega, H.
    Conaghan, P. G.
    Emery, P.
    Ponchel, F.
    Freeston, J. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 456 - 462
  • [10] Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
    Antonia Boman
    Heidi Kokkonen
    Lisbeth Ärlestig
    Ewa Berglin
    Solbritt Rantapää-Dahlqvist
    Clinical Rheumatology, 2017, 36 : 1005 - 1012
12345